World Vaccine Congress Europe 2026 has ended. This guide stays up as the record of who was there. Next: WVC Europe 2027, Oct 25–27, 2027 in Lyon

Infectious disease and AMR at World Vaccine Congress Europe 2026

Oct 19–21, 2026 Amsterdam, Netherlands ~2k attendees Website

91 organizations at World Vaccine Congress Europe 2026 present work in infectious disease & AMR: 39 vaccine and drug developers, 18 public-health and non-profit bodies, 18 suppliers and service providers and 16 academic bodies. Between them they bring 177 presentations to the program. Most represented: Sanofi, GSK and University of Oxford. As of Oct 12, 2026.

All 268 organizations at World Vaccine Congress Europe 2026 →

Format
Top represented
Showing 1–6 of 91 organizations
OrganizationWorld Vaccine Congress Europe 2026 Attendance
Sanofi
Paris, France
Large pharma
Global pharmaceutical company with a large vaccines business spanning influenza, pediatric, meningitis and mRNA programs.
Talk
Mon Oct 19
10:45
mRNA-LNP Platform: Screening, Formulation Optimization and Process Improvements
Workshop: Platform Technologies
Talk
Mon Oct 19
11:30
Immunity Takes Care of Your Skin: The Vaccine Reinventing Acne Treatment
Workshop: Cancer & Therapeutic Vaccines
Talk
Mon Oct 19
14:45
Assessing and Monitoring Vaccine Safety in the AI Era
Workshop: Vaccine Safety & Access
Talk
Mon Oct 19
15:30
Advancing Pandemic Preparedness: Pandemic Flu H5 mRNA program
Workshop: Biothreats & Disease X
Talk
Tue Oct 20
09:00
The Technology Revolution: Agility for the Wave of Next Generation Vaccines
Which newer vaccine platforms, such as RNA, could shorten outbreak response times and extend vaccines to cancer and autoimmune disease.
with European Medicines Agency, Vaccines Europe, International Vaccine Institute +4 more
Platforms & delivery
Talk
Wed Oct 21
12:45
Panel: From Bottleneck to Breakthrough: Reengineering Vaccine Clinical Development
Why vaccine development has slowed back to pre-pandemic speeds and which changes, including AI, could make clinical trials faster.
with PATH, McKinsey & Company, AstriVax
Talk
Wed Oct 21
13:30
Platform leverage in vaccine development: how diversified technologies and adjuvant innovation are reshaping protection for older adults,
Respiratory
Talk
Wed Oct 21
15:00
Panel: Designing Better Vaccine Trials: The Role and Reality of Modelling
Whether models built from manufacturing and early trial data can shrink vaccine trials, and what evidence regulators need to trust them.
with GSK, Swedish Medical Products Agency, European Medicines Agency
GSK
London, United Kingdom
Panel
Mon Oct 19
12:15
Panel: Building Next-Generation Vaccine Platforms: Innovation, Stability, and Scalability
Workshop: Platform Technologies · with CEPI, IAVI, The Francis Crick Institute +1 more
Talk
Mon Oct 19
15:00
Panel: Global Vaccine Access: Balancing Speed and Safety
How regulators worldwide can speed vaccine approval, for example by relying on other agencies' reviews, without weakening safety checks.
with European Medicines Agency, BioNTech, Gates Medical Research Institute +1 more
Panel
Wed Oct 21
10:45
Panel: Emerging Outbreaks at the Front Line: From Early Signals to Real-World Response
How outbreaks like bird flu and hantavirus can be spotted sooner, what vaccines add to the response, and where gaps remain.
with UK Health Security Agency (UKHSA), CSL Seqirus, University of Oxford +1 more
Talk
Wed Oct 21
13:15
Panel
Wed Oct 21
14:30
Panel: Can TB vaccines deliver on the promise?
What tuberculosis vaccine trials can learn from COVID-19, flu and respiratory syncytial virus, and how to make tuberculosis a funding priority.
with London School of Hygiene & Tropical Medicine, Novo Nordisk Foundation Initiative for Vaccines and Immunity, IAVI +2 more
Talk
Wed Oct 21
15:00
Panel: Designing Better Vaccine Trials: The Role and Reality of Modelling
Whether models built from manufacturing and early trial data can shrink vaccine trials, and what evidence regulators need to trust them.
with Swedish Medical Products Agency, Sanofi, European Medicines Agency
Talk
Mon Oct 19
10:00
Workshop Leader’s Opening Remarks
Workshop: Platform Technologies
Talk
Mon Oct 19
11:45
Talk
Tue Oct 20
16:30
Panel
Tue Oct 20
17:00
One Health in Action: Connecting Human, Animal, and Environmental Health to Advance Vaccine Strategy
How tracking disease in people, animals and the environment together can set vaccine priorities for infections that jump from animals, like bird flu.
with Food and Agriculture Organization (FAO), Lyonbiopole, Health Emergency Preparedness and Response Authority +1 more
One Health & ecosystems
Talk
Wed Oct 21
10:30
From crisis to preparedness: vaccine development during and between outbreaks lessons from the Bundibugyo virus (BDBV) PHEIC
Emerging & Infectious Diseases
Panel
Wed Oct 21
10:45
Panel: Emerging Outbreaks at the Front Line: From Early Signals to Real-World Response
How outbreaks like bird flu and hantavirus can be spotted sooner, what vaccines add to the response, and where gaps remain.
with UK Health Security Agency (UKHSA), CSL Seqirus, GSK +1 more
Talk
Wed Oct 21
14:30
Neutralising antibody is a poor predictor of protection by candidate EBV vaccines
Emerging & Infectious Diseases
Moderna
Cambridge, MA
Talk
Mon Oct 19
14:00
Workshop Leader
Workshop: Vaccine Safety & Access
Talk
Mon Oct 19
15:00
Panel: Global Vaccine Access: Balancing Speed and Safety
How regulators worldwide can speed vaccine approval, for example by relying on other agencies' reviews, without weakening safety checks.
with GSK, European Medicines Agency, BioNTech +1 more
Talk
Mon Oct 19
15:15
Moderna’s Clinical Development of Bundibugyo Ebolavirus Vaccine
Workshop: Biothreats & Disease X
Talk
Mon Oct 19
16:15
Panel: From Early Signals to Decisions: The Future of Outbreak Intelligence
How genome sequencing, wastewater testing and health records can flag outbreaks early enough to guide vaccine strain choice and policy.
with UK Health Security Agency (UKHSA), PATH, Erasmus MC +1 more
Talk
Tue Oct 20
10:15
One Shot, Many Frontiers: Combination Vaccines for a Healthier Lifetime
Whether combining several vaccines into one shot raises coverage at every age, and how to keep such shots safe, effective and widely available.
with PATH, Baylor College of Medicine, MHRA +2 more
Infectious disease & AMR
Talk
Wed Oct 21
15:15
Moderna’s Influenza Program
Respiratory
IAVI
New York, NY
Public health & non-profit
Non-profit research organization developing vaccines and antibodies for HIV, tuberculosis and emerging infectious diseases.
Talk
Mon Oct 19
11:30
Vaccine development using recombinant Vesicular Stomatitis Virus (VSV) as platform technology
Workshop: Platform Technologies
Talk
Mon Oct 19
11:45
rVSV technology for Bundibugyo vaccine development
Workshop: Platform Technologies
Panel
Mon Oct 19
12:15
Panel: Building Next-Generation Vaccine Platforms: Innovation, Stability, and Scalability
Workshop: Platform Technologies · with CEPI, GSK, The Francis Crick Institute +1 more
Session
Wed Oct 21
10:30
Track Chair
Bioprocess & Manufacturing
Session
Wed Oct 21
12:15
Track Chair
Bioprocess & Manufacturing
Panel
Wed Oct 21
13:15
Panel: Rethinking AMR Priorities: Choosing the Targets That Move the Needle
How to choose which drug-resistant bacteria to target with vaccines and antibody drugs, using cost-effectiveness models to line up funders and drugmakers.
with World Health Organization (WHO), World Organisation for Animal Health (WOAH), PATH +2 more
Panel
Wed Oct 21
14:30
Panel: Can TB vaccines deliver on the promise?
What tuberculosis vaccine trials can learn from COVID-19, flu and respiratory syncytial virus, and how to make tuberculosis a funding priority.
with London School of Hygiene & Tropical Medicine, Novo Nordisk Foundation Initiative for Vaccines and Immunity, GSK +2 more
PATH
Seattle, WA
Public health & non-profit
Global health non-profit working on vaccine development, delivery and immunization systems in low- and middle-income countries.
Talk
Mon Oct 19
16:15
Panel: From Early Signals to Decisions: The Future of Outbreak Intelligence
How genome sequencing, wastewater testing and health records can flag outbreaks early enough to guide vaccine strain choice and policy.
with UK Health Security Agency (UKHSA), Erasmus MC, Moderna +1 more
Talk
Mon Oct 19
16:45
Assessing the Value of Combination Vaccines
Workshop: Vaccine Delivery
Talk
Tue Oct 20
10:15
One Shot, Many Frontiers: Combination Vaccines for a Healthier Lifetime
Whether combining several vaccines into one shot raises coverage at every age, and how to keep such shots safe, effective and widely available.
with Baylor College of Medicine, MHRA, Moderna +2 more
Infectious disease & AMR
Talk
Wed Oct 21
12:00
Working Group: The way forward: how do we ensure that the priority combination vaccines are developed, licensed and used?
How a new framework ranks which combination vaccines for children matter most, and how to get those vaccines developed, approved and used.
with World Health Organization (WHO), Sciensano, Gavi, the Vaccine Alliance
Supply, safety & access
Talk
Wed Oct 21
12:45
Panel: From Bottleneck to Breakthrough: Reengineering Vaccine Clinical Development
Why vaccine development has slowed back to pre-pandemic speeds and which changes, including AI, could make clinical trials faster.
with Sanofi, McKinsey & Company, AstriVax
Panel
Wed Oct 21
13:15
Panel: Rethinking AMR Priorities: Choosing the Targets That Move the Needle
How to choose which drug-resistant bacteria to target with vaccines and antibody drugs, using cost-effectiveness models to line up funders and drugmakers.
with World Health Organization (WHO), World Organisation for Animal Health (WOAH), IAVI +2 more

Explore the full World Vaccine Congress Europe 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Amsterdam. Leave your work email and we’ll be in touch.

Privacy

Download the full World Vaccine Congress Europe 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers in infectious disease & AMR

Tell us what you sell and we’ll find the people at organizations working on infectious disease & AMR most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse World Vaccine Congress Europe 2026 by

Exhibit hall

Not affiliated with or endorsed by the World Vaccine Congress or its organizers. Submit a correction